Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshara S Raghavendra

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Magnetic Resonance Imaging Clinics of North America|April 7, 2018
How Does MR Imaging Help Care for the Breast Cancer Patient? Perspective of a Medical OncologistAkshara S Raghavendra, Debu Tripathy
JCO Oncology Practice|May 15, 2024
Breast Cancer Brain Metastasis: A Comprehensive ReviewAkshara S Raghavendra, Nuhad K Ibrahim
Clinical Journal of Oncology Nursing|May 23, 2022
Oral Oncolytics: Using Remote Technology to Improve Access, Operational Efficiency, and SatisfactionAbbey Kaler, Victoria McClosky, Akshara S Raghavendra, et al.
JAMA Network Open|April 28, 2025
Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaAkshara S Raghavendra, Roland Bassett, Senthil Damodaran, et al.
Breast Cancer Research and Treatment|April 13, 2019
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)Luis Baez-Vallecillo, Akshara S Raghavendra, Kenneth R Hess, et al.
JCO Clinical Cancer Informatics|August 5, 2021
Prognostic Model for De Novo and Recurrent Metastatic Breast CancerCarlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
NPJ Breast Cancer|March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practiceRashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Journal of Surgical Oncology|January 28, 2020
Factors associated with MRI detection of occult lesions in newly diagnosed breast cancersJulie Wecsler, Young Ju Jeong, Akshara S Raghavendra, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Magnetic Resonance Imaging Clinics of North America|April 7, 2018
How Does MR Imaging Help Care for the Breast Cancer Patient? Perspective of a Medical OncologistAkshara S Raghavendra, Debu Tripathy
JCO Oncology Practice|May 15, 2024
Breast Cancer Brain Metastasis: A Comprehensive ReviewAkshara S Raghavendra, Nuhad K Ibrahim
Clinical Journal of Oncology Nursing|May 23, 2022
Oral Oncolytics: Using Remote Technology to Improve Access, Operational Efficiency, and SatisfactionAbbey Kaler, Victoria McClosky, Akshara S Raghavendra, et al.
JAMA Network Open|April 28, 2025
Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaAkshara S Raghavendra, Roland Bassett, Senthil Damodaran, et al.
Breast Cancer Research and Treatment|April 13, 2019
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)Luis Baez-Vallecillo, Akshara S Raghavendra, Kenneth R Hess, et al.
JCO Clinical Cancer Informatics|August 5, 2021
Prognostic Model for De Novo and Recurrent Metastatic Breast CancerCarlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
NPJ Breast Cancer|March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practiceRashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Journal of Surgical Oncology|January 28, 2020
Factors associated with MRI detection of occult lesions in newly diagnosed breast cancersJulie Wecsler, Young Ju Jeong, Akshara S Raghavendra, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
Pageof 2